RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.42B
AUM Growth
-$48.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
97
New
Increased
Reduced
Closed

Top Buys

1
+$31.5M
2
+$21.5M
3
+$17M
4
MCK icon
McKesson
MCK
+$14M
5
ELV icon
Elevance Health
ELV
+$9.32M

Top Sells

1
+$33.7M
2
+$20.4M
3
+$14M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$9.23M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$9.09M

Sector Composition

1 Healthcare 96.82%
2 Industrials 1.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$19.9M 1.4%
60,000
-7,500
27
$19M 1.34%
150,000
-60,000
28
$18.9M 1.33%
100,000
-35,000
29
$18.9M 1.32%
290,000
-90,000
30
$18.8M 1.32%
135,000
-65,419
31
$18.7M 1.31%
300,000
+40,000
32
$18.6M 1.31%
180,000
33
$18.6M 1.3%
240,000
+80,000
34
$18.5M 1.3%
561,269
+256,269
35
$18.2M 1.28%
75,000
36
$17.6M 1.23%
123,600
-20,600
37
$17.3M 1.21%
60,000
-15,000
38
$17.2M 1.21%
180,000
+25,000
39
$17.1M 1.2%
63,333
40
$16.6M 1.16%
507,002
+167,002
41
$16M 1.12%
429,728
42
$14.4M 1.01%
750,000
43
$14.3M 1%
59,450
+10,250
44
$13.7M 0.96%
325,000
+25,000
45
$12.1M 0.85%
550,000
46
$12M 0.84%
240,000
47
$12M 0.84%
180,000
+95,000
48
$11.9M 0.83%
105,000
-5,000
49
$11.4M 0.8%
545,160
50
$9.11M 0.64%
95,000
-10,000
1
2
3 4